ABSTRACT: Although the number of patients with intervertebral disc (IVD) degeneration is increasing in aging societies, its etiology and pathogenesis remain elusive and there is currently no effective treatment to prevent this undesirable condition. The unfolded protein response (UPR) is a cellular machinery that plays critical roles in handling endoplasmic reticulum (ER) stress, a condition caused by the accumulation of unfolded proteins in the ER lumen. This study aimed to elucidate the potential role of the UPR mediated by pancreatic endoplasmic reticulum kinase (PERK), one of the major ER stress sensors in mammalian cells, in the development of IVD degeneration. IVD degeneration was artificially induced in Wister rats by percutaneously puncturing the coccyx IVDs and human IVDs were collected from patients who underwent spinal surgery. Expression of the UPR target genes was elevated in degenerative IVDs in both humans and rats. The induction of ER stress in annulus fibrosus cells significantly increased the transcripts for tumor necrosis factor alpha (TNF-a) and interleukin 6 (IL-6) in a nuclear factor (NF)-kB pathway-dependent manner. The expression of TNF-a and IL-6 was significantly reduced by treatment with a selective PERK inhibitor, GSK2606414, and by gene silencing against PERK and activating transcription factor 4 (ATF4) transcripts. Our findings indicate that the UPR mediated by the PERK pathway is causally related to the development of IVD degeneration, suggesting that PERK may be a potential molecular target for suppressing the degenerative changes in IVDs. ß
Intervertebral disc (IVD) consists of the inner and outer components; the nucleus pulposus (NP) and annulus fibrosus (AF), respectively. NP is derived from the notochord, a rod-like structure of mesodermal origin. AF is a fibrous cartilage tissue composed of the inner and outer coaxial lamella. 1 IVD degeneration is associated with various spine disorders, including back pain, spinal osteoarthritis, and IVD herniation. The development of IVD degeneration is affected by various factors, such as aging, biomechanical stress, and smoking. [2] [3] [4] Past studies have revealed that IVD degeneration is causally related to chronic inflammation, degradation of the extracellular matrix, oxidative stress, and changes in IVD cell populations. [5] [6] [7] [8] Although the number of patients with IVD degeneration is increasing in aging societies, its etiology and pathogenesis remain elusive and there is currently no effective treatment to prevent this undesirable condition. Considering the cost of the current therapy for the patients with degenerative spinal disorders, the development of therapeutic option for IVD degeneration is mandatory to contribute to medical economy.
Secreted proteins are synthesized in the endoplasmic reticulum (ER), which is where they achieve their three-dimensional structure. [9] [10] [11] Cellular stresses such as the overproduction of proteins, hypoxia, low glucose, intracellular calcium fluctuation, and ultraviolet exposure can result in deterioration of the milieu of the ER and compromise the ER's functions. [9] [10] [11] As a result, proteins fail to achieve their proper structure and accumulate in the ER, leading to a pathological condition referred to as ER stress. To address this condition, cells are equipped with a machinery called the unfolded protein response (UPR). Upon ER stress, the UPR is activated and triggers a cascade of events that ultimately lead to the degradation and removal of the misfolded proteins and an expansion of the protein synthesis capacity of the ER. [9] [10] [11] However, under chronic or overt ER stress, the UPR triggers apoptosis to avoid further damage to the surrounding milieu and cells.
In mammalian cells, there are three major stress sensors in the ER that play crucial roles in transmitting ER stress signals to the nucleus: Inositolrequiring protein-1a (IRE1a), activating transcription factor 6 (ATF6), and pancreatic ER kinase (PERK). Under physiological conditions, these stress sensor molecules are inactivated through binding to the ERresident chaperone binding immunoglobulin protein.
Once activated by ER stress, PERK phosphorylates eukaryotic translation initiation factor 2a (eIF2a), suppressing overall protein synthesis. 12 In contrast, the phosphorylation of eIF2a selectively promotes the translation of activating transcription factor 4 (ATF4). ATF4 induces the transcription of genes that are involved in protein folding, antioxidant responses, autophagy, and amino acid metabolism, thereby promoting cell survival. 13 However, under certain conditions, ATF4 induces apoptosis through promoting the transcription of C/EBP homologous protein (CHOP). PERK is therefore considered to be a key regulator of cell fate decision in cells under ER stress. Accordingly, past studies have revealed that PERK is involved in the pathogenesis of various disorders, including Alzheimer's disease, Parkinson's disease, and osteoarthritis, 10, 14, 15 and that the abrogation of PERK activity ameliorates the course of these disorders. 16, 17 In the present study, our aim was to elucidate the potential involvement of the UPR mediated by PERK in the pathogenesis of IVD degeneration. Considering that the phenotype of NP cells differs depending on species while AF cells are homogeneous regardless of age and species, AF was focused to assess the degenerative change of IVD in this study. 18 We showed that the UPR was activated in degenerative IVDs in rats and humans, and that the UPR mediated by the PERK pathway enhanced the expression of inflammatory cytokines involved in the development of IVD degeneration. Of note, we found that pharmacological inhibition of PERK activity by a selective inhibitor suppressed the ER stressinduced production of inflammatory cytokines. Taken together, our data suggest that PERK-mediated UPR is causally related to the development of IVD degeneration through inducing inflammatory factors, and that PERK is a potential molecular target for treating patients with degenerative IVDs.
MATERIALS AND METHODS

Human IVD Samples
Written informed consent was obtained from each patient for the experimental use of surgical samples in accordance with the Keio University Hospital Ethics Guideline (approval number, 20110222). For immunohistochemistry and electron microscope examinations, IVD tissues were collected from patients who underwent spinal fusion surgery for disorders with degenerative IVDs (13 specimens from eight donors; Table 1 ). The degree of IVD degradation was evaluated on the basis of the Pfirrmann grading system, using preoperative magnetic resonance imaging (MRI). 19 Non-degenerative control specimens were collected from two deceased patients who were subjected to autopsy (Table 1) . Written informed consent was obtained from guardians of the participants according to the Keio University Hospital Ethics Guideline (approval number, 20140333).
Electron Microscope Examination IVD tissues were fixed in 2.5% glutaraldehyde/phosphatebuffered saline for 24 h and were incubated on ice with 1% osmium tetroxide for 2 h. Fixed tissues were dehydrated through a graded series of ethanol, and infiltrated with resin. The specimens were placed in a mold and incubated at 45˚C for 1 d, 55˚C for 1 d, and 60˚C for 2 d. Ultrathin sections were prepared using an Ultracut S microtome (Leica, Wetzlar, Germany) and stained with uranyl acetate and lead citrate. Sections were examined with a JEM-1400Plus electron microscope (JEOL, Tokyo, Japan).
Rat IVD Degeneration Model
Eight-week-pld female Wistar rats were purchased from Clea Japan (Tokyo, Japan). The rats were kept under pathogen-free conditions and cared for in accordance with the guidelines of Keio University School of Medicine. Percutaneous IVD puncture (at the level of the 3rd-10th coccygeal vertebrae) was performed using a 23-gauge needle as previously described. 20, 21 A total of 18 rats were sacrificed. A total of nine IVDs were used in each group. For real-time RT-PCR analysis, AF tissues were dissected through a microscope and homogenized only once 1 week after the puncture. For western blotting, the protein of AF tissues was extracted using Tissue Protein Extraction Reagent 1 month after puncture. Immunohistological analysis was performed 2 months after the puncture. All animal 
Immunostaining
The following antibodies were used in the present study: Antihuman phosphorylated-PERK (diluted 400-fold; Novus Biological, Littleton, CO), anti-human ATF4 (diluted 400-fold; Santa Cruz Biotechnology, Dallas, TX), anti-human GADD153/ CHOP (diluted 400-fold; Novus Biological), anti-rat GADD153/ CHOP (diluted 400-fold; Novus Biological), and horseradish peroxidase-conjugated goat anti-rabbit IgG (diluted 200-fold; Sigma-Aldrich, St. Louis, MI). Bound secondary antibodies were visualized using diaminobenzidine (Nacalai Tesque, Kyoto, Japan). Nuclei were counterstained with hematoxylin. Antigen retrieval was achieved by pressure-cooking in citrate buffer (pH 6.0) for 20 min. All specimens were examined under a microscope (BZ-9000; Keyence, Osaka, Japan). Image analysis (including the enumeration of cells) was performed using Image J software (https://imagej.nih.gov/ij/).
Isolation and Culture of Annulus Fibrosus Cells AF tissues were digested using Pronase E (0.04%) (SERVA, Heidelberg, Germany) for 1 h at 37˚C and collagenase P (0.025%) (Roche Diagnosis, Tokyo, Japan) for 4 h at 37˚C. Isolated cells were washed with Dulbecco's Modified Eagle's Medium (DMEM; Invitrogen, Carlsbad, CA) containing 5% fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS), cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin, and maintained in a humidified incubator containing 5% CO 2 at 37˚C. 22 Human and rat AF cells were used within three and five passages, respectively. Considering that loss of adequate nutrient supply was associated with the development of IVD degeneration and that nutrient starvation induces the UPR, 23, 24 human AF cells were cultured under FBS-depleted conditions. Reagents Tunicamycin (TM) was purchased from Calbiochem (San Diego, CA). A selective PERK inhibitor, GSK2606414, was obtained from LKT Laboratories (St Paul, MN). An NF-kB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), was synthesized as previously described. 25 Real-Time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Total RNA was isolated from AF cells using the RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) or the TRIzol Reagent (Thermo Fisher Scientific, Waltham, MA). First-strand cDNA was prepared using the Prime Script RT Reagent Kit (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. Real-time RT-PCR analysis was performed using the Thermal Cycler Dice Real-Time System and SYBR Premix Ex Taq (Takara Bio), and the results were quantified using the ddCt method. Expression levels were normalized to the expression of b-actin transcripts. The nucleotide sequences of the oligonucleotides used in the present study are presented in Table 2 .
Western Blotting
Total cell protein was extracted using the Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, Waltham, MA). Cell lysates were run on SDS-PAGE, transferred onto polyvinylidene fluoride membranes (ATTO Corporation, Tokyo, Japan), and subjected to immunoblotting analysis. The following antibodies were used in the present study: Anti-CHOP (1:1000; Novus Biological), anti-ATF4 (1:1000; Santa Cruz Biotechnology), anti-cleaved caspase-3 (1:1000; Cell Signaling Technology, Danvers, MA), anti-p65 (1:1000; Cell Signaling Technology), anti-phosphorylated p65 (1:1000; Cell Signaling Technology), and b-actin (1:1000; Cell Signaling Technology). Bound antibodies were visualized using the ECL Western Blotting Detection Reagent (GE Healthcare, Uppsala, Sweden). Each experiment was independently carried out three times.
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) Assay Apoptotic cells were identified using an Apoptosis in situ Detection Kit Wako (Wako Pure Chemical Industries, Ltd., Tokyo, Japan), according to manufacturer protocols. To visualize the nuclei, the cultures were incubated with DAB for 5 min.
Lentivirus-Mediated shRNA Knockdown
For the gene silencing experiments, human AF cells were transfected with lentivirus harboring shRNA that targeted the transcripts for PERK, ATF4, or CHOP (TRCN0000262374, TRCN0000013573, and TRCN0000364393, respectively; Sigma-Aldrich). Lentivirus with a non-targeting shRNA was used as a control (SHC002V, Sigma-Aldrich). Cells were collected 72 h after transfection for gene expression analysis.
Statistical Snalysis
All measurements were performed in triplicate. Data are presented as the mean AE standard deviation (SD). Differences between the groups were analyzed by Student's t test, analysis of variance (ANOVA) and Dunett's significance test, with p < 0.05 considered statistically significant.
RESULTS
Expression of the UPR Target Genes Was Enhanced in the IVDs in an IVD Degeneration Rat Model
To elucidate the potential involvement of the UPR in the development of IVD degeneration, we first investigated whether the expression of the UPR-related genes also increased in an IVD degeneration rat model, in which degenerative IVD-like changes were artificially induced by puncturing the IVDs. Histological analysis confirmed the degenerative changes, such as a decrease or loss of the NP tissues and disorganized AF lamellae, in the puncture-treated group (Tx) but not in the sham-treated group (sham) (Fig. 1A) . Furthermore, real-time RT-PCR analysis showed that the transcripts for Tnf and Il6, which are known to be involved in the pathogenesis of IVD degeneration, were significantly higher in the AF area of IVDs of the Tx group than the sham group, as well as UPR target genes, including CHOP (encoded by Ddit3), and homocysteine-induced ER protein (HERP, encoded by Herpud1) (Fig. 1B) . Immunohistochemistry showed a marked increase in the number of AF cells that were positive for phosphorylated-PERK, ATF4, and CHOP staining in the Tx group compared to the sham group (Fig. 1C) . Western blotting confirmed the increased protein expression of phosphorylated-PERK, ATF4, and CHOP in the Tx group, compared to the sham group (Fig. 1D) . These results indicated that activation of the UPR was associated with IVD degeneration in rats.
The PERK-ATF4 Pathway was Activated in Human Degenerative IVDs Given the potential relation between the UPR and IVD degeneration in rats, we sought to elucidate whether this was also the case in humans. We collected highly degenerated IVD specimens from three patients with lumbar degenerative scoliosis or spondylolisthesis (Table 1) , and examined the sections under an electron microscope. As shown in Figure 2A , the ER in the AF cells appeared swollen and disorganized, indicative of the overt retention of proteins in the ER lumen and of chronic ER stress. In accordance, we found that the AF cells in degenerative IVDs were stained positive for phosphorylated-PERK, ATF4, and CHOP, whereas these UPR-related molecules were not expressed the control specimens (Fig. 2B) . Notably, there was a positive correlation between the ratio of the cells positive for these molecules and the degree of IVD degeneration (Fig. 2C) , indicating that activation of the UPR and IVD degeneration were also correlated in humans.
The PERK Pathway was Physiologically Activated in NP Cells
To access the involvement of the UPR in non-degenerate NP cells, we also investigated the expression of the UPR-related genes in NP of rat sham group and human fetal samples. Immunohistochemistry showed a marked increase in the number of NP cells that were positive for phosphorylated-PERK, ATF4, and CHOP in the NP of rat sham group (Fig. 3A) and in human fetal NP (Fig. 3B) , indicating that the PERK pathway is activated in non-degenerate NP cells.
The PERK Pathway Regulated the Expression of the Catabolic Factors Involved in the Development of IVD Degeneration in AF Cells
We next investigated how pharmacological induction or inhibition of the UPR in AF cells affected the gene expression profile. Primary rat AF cells collected from control rats were incubated in the presence of TM or dithiothreitol (DTT), reagents that are widely used to induce ER stress in cell-based experiments. 26 We found that treatment with either of these reagents significantly increased the mRNA expression of TNF-a, IL-6, ADAMTS4, ADAMTS5, MMP3, MMP13, and collagen type 1 (encoded by Col1a1), as well as the UPR target genes, including ATF4, CHOP, and HERP, whereas that of aggrecan and collagen type 2 (encoded by Col2a1) tended to be decreased ( Fig. 4A and B) .
To investigate whether the PERK pathway was involved in the enhanced expression of the transcripts for the catabolic factors, we suppressed the activity of PERK using GSK2606414, a selective PERK inhibitor that targets the inactive form of PERK at the ATPbinding region. Primary human AF cells collected from patients with degenerative IVDs were cultured with GSK2606414 or vehicle under FBS-depleted conditions to induce ER stress. Induction of the UPR target genes (HERP, DDIT, and ATF4) in human AF cells by serum starvation was confirmed by real-time PCR analysis (Fig. 5A) . We found that pharmacological inhibition of PERK significantly suppressed the starvation-induced expression of TNF and ADAMTS5 transcripts in human AF cells (Fig. 5B) . Considering that the PERK pathway is also involved in ER stress-induced apoptosis, we evaluated the frequency of apoptotic cells by TUNEL staining in GSK2606414-treated cells. In addition, protein expression levels of cleaved caspase-3, one of the critical enzymes that trigger apoptosis, was measured by Western blotting in the cells. The starvation-mediated induction of frequency for TUNEL-positive cells were clearly suppressed by the treatment of GSK2606414 (Fig. 5C ). Western blotting and the following densitometry analysis also demonstrated that treatment with GSK2606414 markedly suppressed the expression of cleaved caspase-3 in human AF cells in a dose-dependent manner (Fig. 5  D) . These results indicated that starvation-induced apoptosis in the AF cells was, at least in part, mediated by PERK (Fig. 5E) .
With the aim of consolidating the potential involvement of the PERK pathway in the transcriptional regulation of the catabolic factors, we next performed knockdown experiments by introducing into human AF cells the lentivirus harboring shRNA against the transcripts for PERK, ATF4, or CHOP. The efficacy of gene-silencing of each transcript was approximately 44-58% (Fig. 5F-H) . The expression of the transcripts for TNF and IL6 was significantly suppressed by Fig. 5E and F) . Conversely, the gene-silencing of the transcripts for CHOP exhibited positive effect on the expression of these genes (Fig. 5G ). These observations suggested that the enhanced expression of inflammatory cytokines driven by the activated UPR was in part dependent on PERK and ATF4, but not on CHOP, in human AF cells.
The UPR Induced the Expression of Inflammatory Cytokines Through NF-kB Signaling in AF Cells
Because NF-kB signaling plays a critical role in the pathogenesis of IVD degeneration, 8 we examined whether activation of the UPR led to enhanced NF-kB transcriptional activity in rat AF cells. Notably, we found that pharmacological induction of the UPR using TM and DTT significantly increased the expression of the transcripts for Trib3 (which encodes tribbles pseudokinase 3), one of the target genes of the NF-kB signaling pathway in rat AF cells (Fig. 6A) . Conversely, the expression of the transcripts for TRIB3 was significantly suppressed by gene-silencing of ATF4. The gene-silencing of the transcripts for PERK and CHOP showed less effect on the expression of TRIB3, compared with ATF4 (Fig. 6B) . Accordingly, treatment with TM markedly induced the phosphorylation of p65, a subunit of NF-kB in these cells (Fig. 6C) . Furthermore, suppression of the NF-kB signaling pathway using DHMEQ, an NF-kB inhibitor, significantly reduced the expression levels of the transcripts for TNF and IL6 in the TM-treated cells (Fig. 6D) . Taken together, these observations suggested that the enhanced expression of the inflammatory cytokines induced by the UPR was mediated by the NF-kB signaling pathway in human AF cells.
DISCUSSION
To the best of our knowledge, this is the first study to show the potential involvement of the UPR mediated by the PERK pathway in the pathogenesis of IVD degeneration. We showed that the PERK pathway was activated in human and rat degenerative IVDs, and that induction of the UPR in human and rat AF cells caused a catabolic shift in a PERK pathway-dependent manner. Notably, we found that NF-kB signaling was activated following UPR induction and that inhibition of the NF-kB signaling abolished the UPR-mediated catabolic shift (Fig. 6E) .
ER stress and the ensuing UPR are causally related to the pathogenesis of a wide range of diseases, including neurodegeneration, cancer, and metabolic disorders. 10, 14, 15 In the field of musculoskeletal disorders, a recent study demonstrated that chondrocytes were constantly exposed to ER stress in human osteoarthritis and that CHOP played an important role in ER stress-induced apoptosis and cartilage degeneration. 27 Conversely, the potential contribution of ER stress to IVD degeneration has remained widely unaddressed. In the present study, we found that the expression levels of the UPRrelated genes and catabolic factors correlated positively with IVD degeneration in rats. Furthermore, a transmission electron microscopy study using human degenerative IVD specimens revealed that the ER in the AF cells appeared to be swollen and structurally disorganized, indicative of overt protein retention in the ER in these cells. Accordingly, the expression levels of phosphorylated-PERK, ATF4, and CHOP were all increased in degenerative human IVDs compared with the healthy controls. These data are in line with the notion that the UPR is also involved in the development of IVD degeneration in rats and humans. Additionally, our results showed that the stronger increase in CHOP is observed for all stages of human degenerative samples, compared to phosphorylated-PERK and ATF4. CHOP is known to operate as a downstream component of all UPR pathways. 11 Considering that the pathway of IRE1 and ATF6, as well as PERK are activated by ER stress condition, the expression of CHOP may be more responsive to progression of IVD degeneration.
In the current study, analysis of NP cells was not carried out to assess the degenerative change of IVD. On the other hand, we found that PERK pathway was activated in rat and human non-degenerate NP cells. Considering that NP exists in the center of IVD, the biggest avascular tissue in human body and the anatomical features make NP hypoxic, 28 our results are consistent with previous study that the hypoxia impairs protein folding in the ER and activates UPR. 9 IVD degeneration is usually accompanied by chronic inflammation with the increased expression of proinflammatory cytokines such as TNF-a, IL-1b, and IL-6. 8 These cytokines are produced by both IVD cells and immune cells and they promote the expression of various catabolic mediators, including ADAMTS-4, ADAMTS-5, MMP-3, and MMP-13 in IVD cells. 8, 29 Data emerging over the past decade have revealed that the UPR also has a role in mediating the inflammatory response under both physiological and pathological conditions. [30] [31] [32] On the basis of these data, we hypothesized that the UPR-induced inflammation is also causally related to the pathogenesis of IVD degeneration. We found that the UPR-induced expression of TNF-a and IL-6 was, at least in part, dependent on PERK and ATF4 in AF cells, indicating that PERK-mediated by UPR has a critical role in regulating the inflammatory response, as has recently been reported. 33 On the other hand, our results unexpectedly showed that the expression of the inflammatory cytokines was significantly increased by suppressing CHOP expression. Consistent with our results, previous study reported that the expression of IL-6 was significantly increased by silencing of CHOP expression in human proximal tubular cells. 34 Additionally, Hayashi, et al. 35 also reported that CHOP negatively regulated NF-kb signaling in human T cells. In order to maintain the balance of NF-kb signaling in these cells, CHOP may have the opposite function to PERK and ATF4. Consistent with past studies, [26] [27] [28] [29] we also found that the NF-kB signaling pathway was activated upon ER stress and that pharmacological inhibition of the NF-kB signaling pathway attenuated the UPR-mediated expression of inflammatory cytokines. Although how the UPR signaling activates NF-kB is not fully understood, past studies have shown that translational repression of IkB through PERK and IRE1a increases the ratio of NF-kB to IkB, and thereby promotes the nuclear translocation of NF-kB. 36, 37 These observations underline the essential role of the PERK pathway in the UPR-mediated NF-kB activation.
Targeting of the PERK pathway has been shown to be beneficial in alleviating the progression of neurodegenerative disorders in mice. 16, 17, 38 Although the continuous intake of GSK2606414 was associated with mild toxicity, resulting in weight loss and mild hyperglycemia, suppression of eIF2a-mediated translation through PERK inhibition conferred neuroprotection in an Alzheimer's disease mouse model. 17 In the present study, we found that pharmacological inhibition of PERK by GSK2606414 attenuated starvation-induced apoptosis and suppressed the expression of catabolic factors in human AF cells. These observations indicate that pharmacological inhibition of PERK activity is a potential treatment modality against IVD degeneration. Considering the ubiquitous expression of PERK and the potential side effects of systemic inhibition of PERK in vivo, it would be more practical in clinical use to administer the agent locally rather than systemically inject it. Studies are in progress to assess the efficacy and safety of local injection of GSK2606414 in IVD degeneration rat models.
There were several limitations in the present study. The potential contributions of other UPR pathways in the pathogenesis of IVD degeneration and the molecular mechanism behind the UPR-mediated NF-kB activation need further investigation in future studies. Most importantly, it remains to be elucidated by what and how UPR is triggered in the AF cells. Because AF cells do not produce a large amount of extracellular proteins and are relatively inert, at least under physiological conditions, overproduction of secreted proteins does not appear to be the primary cause of the ER stress. Given that IVDs are the largest avascular tissue in the body and that nutrients and oxygen have to be passively passed through the IVD matrix, it is likely that any minor deterioration in the milieu of the IVD matrix can compromise its ability to diffuse oxygen and nutrients and ultimately trigger ER stress in the IVD cells. Indeed, it is tempting to speculate that an accumulation of degenerative changes in the IVD matrix (caused by aging, biomechanical stress, etc.) is what initially triggers ER stress in the AF cells, and that the ensuing UPR serves to initiate a vicious cycle of IVD degeneration through inducing catabolic factors and thereby further damaging the IVD matrix. Although more studies are required to address this hypothesis, this may also explain why IVD degeneration is an irreversible and progressive event in humans and why a single puncture to the IVDs promotes IVD degradation in rodents. 7, 39 In summary, our data strongly supports the idea that the UPR mediated by the PERK pathway is causally involved in the development of IVD degeneration. Despite some limitations, the present study sheds a novel light on the biology of IVD degeneration and suggests that pharmacological inhibition of the PERK pathway may be a potential therapeutic option for treating patients with IVD degeneration.
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